Inactive Instrument

Calendar RXi Pharmaceuticals Corp Nasdaq

Equities

US74979C8082

Chart calendar RXi Pharmaceuticals Corp

ea2fed89ac94e1f9.j9y0FY2a5R1e0qmTrw8KwmdRDzjcHaGlarpY8xkTM3Q.36rbRebDlEtmv_jX1XddrwQmaw_vRdLOGMIyoitJCwTIkd9Utd2xdR-Kxg~b154b03fe3d2504ce2043a98be66def5

Upcoming events on RXi Pharmaceuticals Corp

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-12 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)

Past events on RXi Pharmaceuticals Corp

2024-03-26 Q4 2023 Earnings Release (Projected)
2024-03-22 01:00 pm Immunotherapy of Cancer Conference
2024-03-21 01:00 pm Immunotherapy of Cancer Conference
2024-03-21 01:00 pm Immunotherapy of Cancer Conference - Poster No : P01.03
2023-11-09 04:30 pm Q3 2023 Earnings Release
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number : 474
2023-10-14 12:30 pm AACR NCI EORTC International Conference - INTASYL™ self-delivering RNAi therapeutic targeting BRD4 e
2023-10-14 12:30 pm AACR NCI EORTC International Conference - INTASYL™ PH-894 self-delivering RNAi targeting BRD4
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-10 04:30 pm Q2 2023 Earnings Release
2023-07-20 09:00 am Annual General Meeting
2023-05-17 03:00 pm American Society of Gene & Cell Therapy Meeting - Abstract No: 544
2023-05-11 05:00 pm Q1 2023 Earnings Release
2023-04-18 01:30 pm American Association for Cancer Research Meeting
2023-04-17 09:00 am American Association for Cancer Research Meeting - Intratumoral PH-762
2023-03-22 05:05 pm Q4 2022 Earnings Release
2023-01-25 Reverse Split: 1 of 12
2023-01-07 Dermatology Summit
2022-11-11 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract #: 1402
2022-11-11 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract #:788

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,14
0,10
38%
0,02
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-7,36
-7,60
3.11%
-8,99
-8,60
-4.5%
-8,79
-8,80
0.08%
-13,5
-14,4
6.17%
-11,5
-12,4
7.56%

-12,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-7,36
-7,60
3.16%
-8,91
-8,50
-4.8%
-8,79
-8,80
0.07%
-13,3
-14,2
6.43%
-11,5
-12,4
7.42%

-12,0

Net income
Million USD
Released
Forecast
Spread
-7,36
-7,60
3.16%
-8,91
-8,50
-4.8%
-8,79
-8,80
0.07%
-13,3
-14,2
6.43%
-11,5
-12,4
7.42%

-12,0

EPS
USD
Released
Forecast
Spread
-686
-1 195
42.54%
-232
-224
-3.37%
-23,0
-23,0
0%
-12,5
-13,3
6.31%
-10,1
-10,9
7.51%

-6,26

Announcement Date27/03/1926/03/2025/03/2122/03/2222/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
12,5
-
0,00
0,00
-



0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-3,74
-3,40
-9.97%
-3,45
-4,40
21.59%
-2,64
-4,10
35.61%
-2,52
-4,10
38.51%
-3,57
9,90
-136.07%
-2,73
-3,70
26.22%



-2,78
-2,80
0.86%

-3,10

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,74
-3,40
-10.06%
-3,45
-4,40
21.57%
-2,64
-4,10
35.56%
-2,53
-4,10
38.27%
-3,58
9,90
-136.12%
-2,73
-3,70
26.19%



-2,78
-2,80
0.71%

-3,10

Net income
Million USD
Released
Forecast
Spread
-3,74
-3,40
-10.06%
-3,45
-4,40
21.57%
-2,64
-4,10
35.56%
-2,53
-4,10
38.27%
-3,58
7,50
-147.68%
-2,73
-3,70
26.19%
-2,55


-2,78
-2,80
0.71%

-3,10

EPS
USD
Released
Forecast
Spread
-3,36
-3,00
-12%
-3,12
-3,84
18.75%
-2,28
-3,60
36.67%
-2,28
-3,72
38.71%
-3,12
4,32
-172.22%
-2,42
-3,24
25.31%
-1,47


-1,14
-1,43
20.28%

-1,30

Announcement Date10/11/2122/03/2212/05/2211/08/2210/11/2222/03/2310/08/2309/11/23-